By Benjamin Chiou
Date: Tuesday 14 Apr 2026
(Sharecast News) - Pharmaceutical and medical tech group Johnson & Johnson raised its 2026 outlook on Tuesday after first-quarter results marginally beat Wall Street estimates on the back of strong growth from its oncology drug portfolio.
By Josh White
Date: Thursday 19 Feb 2026
(Sharecast News) - First Development Resources reported encouraging rare-earth element stream sediment results from its Selta project in Australia's Northern Territory on Thursday, with assays of up to 2,103 parts per million total rare-earth elements plus yttrium and a significant narrowing of priority target areas.
By Benjamin Chiou
Date: Wednesday 21 Jan 2026
(Sharecast News) - American healthcare and medical device giant Johnson & Johnson matched analysts' estimates with its fourth-quarter results, as earnings jumped on the back of improved sales of cancer and autoimmune drugs.
| Currency | US Dollars |
| Share Price | $ 227.19 |
| Change Today | $ -2.66 |
| % Change | -1.16 % |
| 52 Week High | $248.56 |
| 52 Week Low | $146.36 |
| Volume | 6,863,587 |
| Shares Issued | 2,407.94m |
| Market Cap | $547,060m |
| RiskGrade | 87 |
| Strong Buy | 6 |
| Buy | 8 |
| Neutral | 12 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 26 |

| Time | Volume / Share Price |
| 16:00 | 100 @ $227.21 |
| 16:00 | 989,389 @ $227.19 |
| 16:00 | 461 @ $227.21 |
| 15:59 | 100 @ $227.20 |
| 15:59 | 100 @ $227.20 |
You are here: research